EcoR1 Capital’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

EcoR1 Capital’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-89	Closed	-$502K	–	39
2016 Q4	$502K	Buy	+89	New	+$455K	0.16%	29

Other funds holding TMBR

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

EcoR1 Capital's TMBR Position: Q1 2017 in Review

EcoR1 Capital sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q1 2017, closing a stake of 89 shares — an estimated $502K sold.

EcoR1 Capital first reported a position in TMBR in Q4 2016 and held it in 1 quarter. The position peaked at $502K in Q4 2016. 17 funds tracked by Wall St. Rank hold TMBR as of Q1 2017.

EcoR1 Capital reported no remaining Timber Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
EcoR1 Capital sold 89 Timber Pharmaceuticals, Inc. shares in Q1 2017, an estimated $502K.
EcoR1 Capital first reported a position in Timber Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
EcoR1 Capital's Timber Pharmaceuticals, Inc. position peaked at $502K in Q4 2016.
17 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q1 2017.

Based on EcoR1 Capital's 13F filing for Q1 2017, filed 15 May 2017.